In addition, a clinical study reported a significant positive correlation between hepatic GOT2 mRNA expression and systolic hypertension in patients with non-alcoholic fatty liver disease (Sookoian et al., 2016). This evidence concerns the gene GOT2 and metabolic dysfunction-associated steatotic liver disease.